William B. Horne net worth and biography

William Horne Biography and Net Worth

Director of Alzamend Neuro

William B. Horne has served as a director of our company since June 2016. Mr. Horne served as the Chief Financial Officer from June 2016 through December 2018. Mr. Horne currently serves as Vice Chairman and Chief Executive Officer at Ault Alliance, Inc. (previously "BitNile Holdings, Inc." FKA "Ault Global Holdings") since January 12, 2021. Mr. Horne has been a member of the board of directors of Ault Alliance, Inc. since October 2016. In January 2018, Mr. Horne was appointed as Ault Alliance, Inc.'s Chief Financial Officer until August 2020, when he resigned as its Chief Financial Officer and was appointed as its President.

Mr. Horne previously held the position of Chief Financial Officer in various companies in the healthcare and high-tech field, including OptimisCorp, from January 2008 to May 2013, a privately held, diversified healthcare technology company. Mr. Horne served as the Chief Financial Officer of Patient Safety Technologies, Inc., a medical device company, from June 2005 to October 2008, and as the interim Chief Executive Officer from January 2007 to April 2008. In his dual role at Patient Safety Technologies, Mr. Horne was directly responsible for structuring the divestiture of non-core assets, capital financings and debt restructuring. Mr. Horne has also held supervisory positions at Price Waterhouse, LLP. Mr. Horne holds a B.A. degree in accounting from Seattle University. We believe that Mr. Horne's extensive financial and accounting experience in diversified industries and with companies involving complex transactions gives him the qualifications and skills to serve as one of our directors.

What is William B. Horne's net worth?: The estimated net worth of William B. Horne is at least $683 thousand as of September 29th, 2026. Horne owns 500,000 shares of Alzamend Neuro stock worth more than $683,000 as of October 7th. This net worth approximation does not reflect any other investments that Horne may own. Learn More about William B. Horne's net worth.
How do I contact William B. Horne?: The corporate mailing address for Horne and other Alzamend Neuro executives is 480 Peachtree Road NE, Second Floor, Suite 103, Atlanta, GA, 30326. Alzamend Neuro can also be reached via phone at (844) 722-6333. Learn More on William B. Horne's contact information.
Has William B. Horne been buying or selling shares of Alzamend Neuro?: William B. Horne has not been actively trading shares of Alzamend Neuro over the course of the past ninety days. Most recently, William B. Horne sold 3,333 shares of the business's stock in a transaction on Friday, December 19th. The shares were sold at an average price of $2.12, for a transaction totalling $7,065.96. Learn More on William B. Horne's trading history.
Who are Alzamend Neuro's active insiders?: Alzamend Neuro's insider roster includes Milton Ault III (Major Shareholder), Milton Ault, III (Major Shareholder), Milton Ault, III. (Major Shareholder), Mark Gustafson (Director), William Horne (Director), Lynne Mcgrath (Director), and L. Smith (Insider). Learn More on Alzamend Neuro's active insiders.
Are insiders buying or selling shares of Alzamend Neuro?: During the last year, Alzamend Neuro insiders bought shares 1 times. They purchased a total of 108,388 shares worth more than $108,388.00. During the last year, insiders at the sold shares 7 times. They sold a total of 186,384 shares worth more than $451,682.34. The most recent insider tranaction occured on August, 26th when Director Milton C. Ault III sold 2,000 shares worth more than $3,120.00. Insiders at Alzamend Neuro own 1.4% of the company. Learn More about insider trades at Alzamend Neuro.
Information on this page was last updated on 8/26/2026.

William B. Horne Insider Trading History at Alzamend Neuro

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/19/2025	Sell	3,333	$2.12	$7,065.96
3/26/2025	Buy	370	$8.91	$3,296.70	3,333
3/20/2025	Buy	555	$8.82	$4,895.10	2,962

William B. Horne Buying and Selling Activity at Alzamend Neuro

Alzamend Neuro Company Overview

Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002 stage, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Today's Range

Now: $1.37

$1.34

$1.42

50 Day Range

MA: $1.61

$1.31

$1.94

2 Week Range

Now: $1.37

$0.84

$2.68

Volume

18,195 shs

Average Volume

126,001 shs

Market Capitalization

$6.60 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27